Clinical Trial Update: 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial update of 89Zr-Trastuzumab PET imaging in breast cancer completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 89Zr-trastuzumab (zirconium-89-labeled trastuzumab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Breast Cancer | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2022-10-06